Medications for Sicca Keratoconjunctivitis
7 results
Cequa (cyclosporine)
(cyclosporine)Sun Pharmaceutical Industries, Inc.
Usage: CEQUA ophthalmic solution is indicated for increasing tear production in patients with keratoconjunctivitis sicca (dry eye).
Cyclosporine (cyclosporine)
(cyclosporine)Devatis Inc.
Usage: Cyclosporine ophthalmic emulsion is indicated for increasing tear production in patients with keratoconjunctivitis sicca, particularly when tear production is suppressed due to ocular inflammation. It is not effective in patients already using topical anti-inflammatory drugs or punctal plugs.
Cyclosporine (cyclosporine)
(cyclosporine)Pacific Pharma, Inc.
Usage: Cyclosporine ophthalmic emulsion, 0.05% is indicated to increase tear production in patients with keratoconjunctivitis sicca due to ocular inflammation. It does not increase tear production in patients using topical anti-inflammatory drugs or punctal plugs.
Glostrips (rose bengal sodium)
(Rose Bengal Sodium)Nomax Inc.
Usage: Rose Bengal ophthalmic strips are used for diagnosing ocular conditions, including superficial conjunctival or corneal changes, keratoconjunctivitis sicca, keratitis, abrasions, and foreign body detection during routine eye examinations.
Lacrisert (hydroxypropyl cellulose)
(hydroxypropyl cellulose)Bausch & Lomb Incorporated
Usage: LACRISERT is indicated for moderate to severe dry eye syndromes, including keratoconjunctivitis sicca, particularly in patients not responding to artificial tears. It is also used for exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.
Restasis (cyclosporine)
(cyclosporine)Allergan, Inc.
Usage: RESTASIS® ophthalmic emulsion is indicated for increasing tear production in patients with keratoconjunctivitis sicca related to ocular inflammation. It is not effective in patients using topical anti-inflammatory drugs or punctal plugs.
Restasis multidose (cyclosporine)
(cyclosporine)Allergan, Inc.
Usage: RESTASIS MULTIDOSE ophthalmic emulsion is indicated to increase tear production in patients with keratoconjunctivitis sicca, particularly when tear production is presumed suppressed due to ocular inflammation. It is not effective in patients currently using topical anti-inflammatory drugs or punctal plugs.